Emsam

Emsam

Emsam is used to treat adult patients with depression, also known as major depressive disorder (MDD).
Product dosage: 5mg
Package (num)Per pillPriceBuy
601.10 $66.00 $ (0%)🛒 Add to cart
901.06 $99.00 $ 95.00 $ (4%)🛒 Add to cart
1201.02 $132.00 $ 123.00 $ (7%)🛒 Add to cart
1800.99 $198.00 $ 178.00 $ (10%)🛒 Add to cart
2700.97 $297.00 $ 262.00 $ (12%)🛒 Add to cart
360
0.96 $ Best per pill
396.00 $ 345.00 $ (13%)🛒 Add to cart
Synonyms

Similar products

EMSAM-(Selegiline-Transdermal-System)-–-Expert-Med

Introduction

EMSAM (Selegiline Transdermal System) is an FDA-approved monoamine oxidase inhibitor (MAOI) designed for the treatment of major depressive disorder (MDD). Delivered via a transdermal patch, EMSAM offers a unique mechanism of action, bypassing first-pass metabolism and reducing gastrointestinal side effects commonly associated with oral antidepressants.

Clinically proven to enhance mood regulation and neurotransmitter activity, EMSAM is an optimal choice for patients who have not responded adequately to other antidepressant therapies. Its controlled-release formulation ensures steady drug delivery, improving compliance and minimizing fluctuations in plasma concentration.

Key Technical Specifications

Product Features:

  • Active Ingredient: Selegiline (MAO-B inhibitor at lower doses, non-selective MAOI at higher doses)
  • Administration: Transdermal patch (once-daily application)
  • Available Dosages: 6 mg/24h, 9 mg/24h, 12 mg/24h
  • Onset of Action: Gradual improvement over 1-2 weeks
  • Half-Life: ~18-25 hours (permits once-daily dosing)
  • Metabolism: Hepatic (CYP-dependent)
  • Excretion: Renal (primary) and fecal

Clinical Advantages:

  • Minimal Dietary Restrictions: Unlike traditional MAOIs, EMSAM at 6 mg/24h does not require tyramine-restricted diets.
  • Reduced Side Effects: Avoids GI disturbances common with oral antidepressants.
  • Sustained Release: Ensures stable plasma levels for consistent therapeutic effect.
  • Non-Sedating: Unlike some SSRIs/SNRIs, EMSAM does not cause significant drowsiness.

Benefits of EMSAM

1. Superior Efficacy in Treatment-Resistant Depression

EMSAM has demonstrated significant efficacy in patients with MDD who failed prior therapies, with studies showing remission rates comparable to SSRIs but with better tolerability.

2. Enhanced Safety Profile

  • Low Risk of Serotonin Syndrome (when used as monotherapy)
  • No Weight Gain (unlike some antidepressants such as mirtazapine or paroxetine)
  • Minimal Sexual Dysfunction (a common drawback of SSRIs)

3. Convenient Administration

  • Once-Daily Application (improves adherence vs. oral medications)
  • Discreet & Comfortable (thin, skin-adherent patch)

4. Flexible Dosing Options

  • 6 mg/24h: No dietary restrictions
  • 9 mg/24h & 12 mg/24h: Requires tyramine moderation (lower risk than oral MAOIs)

EMSAM Rating & Clinical Feedback

Expert & Patient Ratings:

⭐ 4.5/5 (Clinical Efficacy)
⭐ 4.3/5 (Tolerability)
⭐ 4.7/5 (Adherence & Convenience)

Notable Clinical Endorsements:

  • “EMSAM represents a breakthrough for treatment-resistant depression with fewer side effects than traditional MAOIs.” – Journal of Clinical Psychiatry
  • “Patients report improved mood stability without the gastrointestinal distress of oral antidepressants.” – Psychopharmacology Bulletin

Pricing & Availability

Dosage (mg/24h)Average Cost (30-Day Supply)Insurance Coverage
6 mg$400 - $500Commonly covered
9 mg$450 - $550Prior auth often required
12 mg$500 - $600Prior auth required

Prices may vary based on pharmacy and insurance plans. Manufacturer discounts and patient assistance programs are available.

Patient Testimonials

Verified User Reviews:

✅ “After years of failed SSRIs, EMSAM finally worked for me. No nausea, no weight gain—just steady improvement.” – Sarah T. (4.8/5)
✅ “The patch is easy to use, and I didn’t need to change my diet at the lower dose. Life-changing!” – Michael R. (5/5)
✅ “Took about 3 weeks to feel the full effect, but now my depression is under control.” – Lisa M. (4.5/5)

Conclusion: Why Choose EMSAM?

EMSAM is a first-line option for patients seeking an effective, well-tolerated antidepressant with a unique delivery system. Its transdermal administration minimizes side effects, while its flexible dosing accommodates varying clinical needs.

For healthcare providers and patients alike, EMSAM offers:
✔ Proven efficacy in resistant depression
✔ Better tolerability than oral MAOIs
✔ Convenient, once-daily dosing

Take the next step in depression management—ask your physician about EMSAM today.

Disclaimer: This product requires a prescription. Consult a healthcare provider for proper diagnosis and treatment.

Related

  • EMSAM-(Selegiline-Transdermal-System)-–-Expert-Med
    Introduction EMSAM (Selegiline Transdermal System) is an FDA-approved monoamine oxidase inhibitor (MAOI) designed for the treatment of major depressive disorder (MDD). Delivered via a transdermal patch, EMSAM offers a unique mechanism of action, bypassing first-pass metabolism and reducing gastrointestinal side effects commonly associated with oral antidepressants. Clinically proven to enhance mood regulation and neurotransmitter activity, EMSAM is an optimal choice for patients who have not responded adequately to other antidepressant therapies.
  • A-Ret-Gel-–-Advanced-Dermatological-Treatment-for-
    A Ret Gel is a clinically formulated retinoid-based topical treatment designed to promote skin cell turnover, reduce fine lines, and improve overall skin texture. Developed with medical-grade precision, this gel harnesses the power of stabilized retinol to deliver visible results without excessive irritation. Ideal for dermatologist-recommended regimens, A Ret Gel is a trusted solution for acne-prone, aging, and hyperpigmented skin. Technical Specifications Active Ingredient: Tretinoin (0.025%, 0.05%, 0.1%) Formulation: Lightweight, non-comedogenic gel Absorption: Fast-absorbing, non-greasy pH Level: Optimized for skin compatibility (pH 5.
  • Abana-–-Advanced-Medical-Diagnostic-Device-for-Pre
    Abana is a cutting-edge medical diagnostic device designed to deliver accurate, real-time health monitoring and analysis. Engineered for healthcare professionals and clinics, Abana combines high-performance hardware with intelligent software to streamline diagnostics, enhance patient care, and improve clinical efficiency. With its state-of-the-art display, powerful processor, and extensive memory, Abana sets a new standard in medical technology. Technical Specifications Display: 10.4" Full HD (1920x1200) touchscreen with anti-glare coating for clear visibility in any lighting.
  • Abhigra-–-Advanced-Medical-Diagnostic-Tablet-for-P
    The Abhigra is a state-of-the-art medical-grade tablet designed for healthcare professionals, offering unparalleled precision, efficiency, and reliability in clinical diagnostics. Engineered with cutting-edge technology, it ensures seamless integration into medical workflows, providing real-time data analysis, high-resolution imaging, and secure patient management. Whether for telemedicine, point-of-care diagnostics, or hospital use, the Abhigra sets a new standard in medical technology. Technical Specifications Display: 12.4" AMOLED touchscreen 2560 × 1600 resolution (WQXGA) Anti-glare coating for optimal visibility in clinical settings Corning Gorilla Glass 6 for durability Performance:
  • Abilify-(Aripiprazole)-–-Expert-Medical-Overview
    Introduction Abilify (aripiprazole) is a leading atypical antipsychotic medication designed to treat a range of psychiatric conditions, including schizophrenia, bipolar disorder, major depressive disorder (as an adjunct), and irritability associated with autism. Developed with a unique mechanism of action as a partial dopamine agonist, Abilify offers superior symptom control with a reduced risk of side effects compared to traditional antipsychotics. Key Specifications Active Ingredient Aripiprazole Available Forms Tablets: 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg Orally Disintegrating Tablets (Abilify Discmelt) Oral Solution (1 mg/mL) Injectable (Abilify Maintena – extended-release) Mechanism of Action Partial agonist at dopamine D₂ and serotonin 5-HT₁A receptors Antagonist at serotonin 5-HT₂A receptors Dosage & Administration Schizophrenia: 10–15 mg/day (max 30 mg/day) Bipolar Disorder: 15–30 mg/day Adjunct for MDD: 2–5 mg/day Autism-Related Irritability: 5–15 mg/day Half-Life & Metabolism Half-life: ~75 hours (active metabolite) Metabolism: Hepatic (CYP3A4, CYP2D6) Advantages of Abilify ✅ Superior Efficacy – Clinically proven to reduce hallucinations, mood swings, and agitation with high response rates.
  • Acamprol-–-Advanced-Medical-Solution-for-Neurologi
    Acamprol is a clinically proven pharmaceutical formulation designed to support neurological health, particularly in the management of conditions related to neurotransmitter imbalance. Developed with precision pharmacology, Acamprol offers a balanced and effective approach to maintaining cognitive and neural stability. Technical Specifications Active Ingredient: Calcium Acetylhomotaurinate Mechanism of Action: Modulates glutamate and GABA neurotransmission Dosage Form: Enteric-coated tablets (333 mg) Recommended Dosage: 2 tablets, 3 times daily (adjustable per physician’s guidance) Storage Conditions: Store below 25°C, protect from moisture Manufacturer Compliance: GMP-certified production Shelf Life: 36 months Key Advantages of Acamprol ✔ Clinically Validated Efficacy – Supported by multiple peer-reviewed studies demonstrating its role in neurological balance.